Glycopeptide sulfation evades resistance

Journal of Bacteriology

Volumn 195, Issue 1, 2013, Pages 167-171

  Kalan, Lindsay ^a   Perry, Julie ^a   Koteva, Kalinka ^a   Thaker, Maulik ^a   Wright, Gerard ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPEPTIDE; TEICOPLANIN; VANCOMYCIN;

ACTINOBACTERIA; ANTIBIOTIC RESISTANCE; ANTIBODY COMBINING SITE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL WALL; BINDING KINETICS; CONTROLLED STUDY; DIMERIZATION; DRUG TARGETING; GENE CLUSTER; MICROBIAL DIVERSITY; NONHUMAN; PRIORITY JOURNAL; SULFATION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CALORIMETRY; CARBON-OXYGEN LIGASES; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GLYCOPEPTIDES; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; STREPTOMYCES; TRANSCRIPTION, GENETIC;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 84872040619     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.01617-12     Document Type: Article

References (23)

1. Arthur M, Molinas C, Bugg TD, Wright GD, Walsh CT, Courvalin P. 1992. Evidence for in vivo incorporation of D-lactate into peptidoglycan precursors of vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 36:867-869.
2. Bugg TD, Wright GD, Dutka-Malen S, Arthur M, Courvalin P, Walsh CT. 1991. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. Biochemistry 30: 10408-10415.
3. Bugg TD, Dutka-Malen S, Arthur M, Courvalin P, Walsh CT. 1991. Identification of vancomycin resistance protein VanA as a D-alanine:Dalanine ligase of altered substrate specificity. Biochemistry 30:2017-2021.
4. Koteva K, Hong HJ, Wang XD, Nazi I, Hughes D, Naldrett MJ, Buttner MJ, Wright GD. 2010. A vancomycin photoprobe identifies the histidine kinase VanSsc as a vancomycin receptor. Nat. Chem. Biol. 6:327-329.
5. Wright GD, Holman TR, Walsh CT. 1993. Purification and characterization of VanR and the cytosolic domain of VanS: a two-component regulatory system required for vancomycin resistance in Enterococcus faecium BM4147. Biochemistry 32:5057-5063.
6. Kahne D, Leimkuhler C, Lu W, Walsh C. 2005. Glycopeptide and lipoglycopeptide antibiotics. Chem. Rev. 105:425-448.
7. Nicolaou KC, Boddy CN, Brase S, Winssinger N. 1999. Chemistry, biology, and medicine of the glycopeptide antibiotics. Angew. Chem. Int. Ed. Engl. 38:2096-2152.
8. Lamb SS, Patel T, Koteva KP, Wright GD. 2006. Biosynthesis of sulfated glycopeptide antibiotics by using the sulfotransferase StaL. Chem. Biol. 13:171-181.
9. Pootoolal J, Thomas MG, Marshall CG, Neu JM, Hubbard BK, Walsh CT, Wright GD. 2002. Assembling the glycopeptide antibiotic scaffold: the biosynthesis of A47934 from Streptomyces toyocaensis NRRL15009. Proc. Natl. Acad. Sci. U.S.A. 99:8962-8967.
10. Skelton NJ, Williams DH. 1990. Structure elucidation of the novel glycopeptide antibiotic UK-68,597. J. Org. Chem. 55:3718-3723.
11. Banik JJ, Brady SF. 2008. Cloning and characterization of new glycopeptide gene clusters found in an environmental DNA megalibrary. Proc. Natl. Acad. Sci. U.S.A. 105:17273-17277.
12. Banik JJ, Craig JW, Calle PY, Brady SF. 2010. Tailoring enzyme-rich environmentalDNAclones: a source of enzymes for generating libraries of unnatural natural products. J. Am. Chem. Soc. 132:15661-15670.
13. Kieser T, Bibb MJ, Buttner MJ, Chater KF, Hopwood DA. 2000. Practical streptomyces genetics, 2nd ed. John Innes Foundation, Norwich, England.
14. Mirgorodskaya OA, Olsufyeva EN, Kolume DE, Joergensen TJD, Roepstorff P, Pavlov AY, Miroshnikova OV, Preobrazhenskaya MN. 2000. The dimerization of semisynthetic eremomycin derivatives studied by the electrospray ionization mass spectrometry and its effect on their antibacterial activity. Russ. J. Bioorg. Chem. 26:566-574.
15. Baptista M, Depardieu F, Courvalin P, Arthur M. 1996. Specificity of induction of glycopeptide resistance genes in Enterococcus faecalis. Antimicrob. Agents Chemother. 40:2291-2295.
16. Hong HJ, Hutchings MI, Hill LM, Buttner MJ. 2005. The role of the novel Fem protein VanK in vancomycin resistance in Streptomyces coelicolor. J. Biol. Chem. 280:13055-13061.
17. Hong H-J, Hutchings MI, Neu JM, Wright GD, Paget MSB, Buttner MJ. 2004. Characterization of an inducible vancomycin resistance system in Streptomyces coelicolor reveals a novel gene (vanK) required for drug resistance. Mol. Microbiol. 52:1107-1121.
18. Hong HJ, Hutchings MI, Buttner MJ. 2008. Vancomycin resistance VanS/VanR two-component systems. Adv. Exp. Med. Biol. 631:200-213.
19. Goh EB, Yim G, Tsui W, McClure J, Surette MG, Davies J. 2002. Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics. Proc. Nat. Acad. Sci. U.S.A. 99:17025-17030.
20. Nitanai Y, Kikuchi T, Kakoi K, Hanamaki S, Fujisawa I, Aoki K. 2009. Crystal structures of the complexes between vancomycin and cell-wall precursor analogs. J. Mol. Biol. 385:1422-1432.
21. Schäfer M, Schneider TR, Sheldrick GM. 1996. Crystal structure of vancomycin. Structure 4:1509-1515.
22. Tesarová E, Tuzar Z, Nesmerak K, Bosakova Z, Gas B. 2001. Study on the aggregation of teicoplanin. Talanta 54:643-653.
23. Lehmann C, Bunkoczi G, Vertesy L, Sheldrick GM. 2002. Structures of glycopeptide antibiotics with peptides that model bacterial cell-wall precursors. J. Mol. Biol. 318:723-732